Bharat Biotech's subsidiary Chiron Behring launches anti-rabies vaccine

“In our ongoing commitment to address the supply shortages of rabies vaccine, we are making additional investments to increase production capacities to over 15 million doses annually,” added Krishna Ella, CMD, Bharat biotech International Ltd. The vaccine is presently manufactured at the WHO pre -qualified facility in Ankleshwar in Gujarat.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news